ATE350660T1 - Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression - Google Patents
Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expressionInfo
- Publication number
- ATE350660T1 ATE350660T1 AT02700679T AT02700679T ATE350660T1 AT E350660 T1 ATE350660 T1 AT E350660T1 AT 02700679 T AT02700679 T AT 02700679T AT 02700679 T AT02700679 T AT 02700679T AT E350660 T1 ATE350660 T1 AT E350660T1
- Authority
- AT
- Austria
- Prior art keywords
- integrin expression
- angionegesis
- studying
- inhibition
- effect
- Prior art date
Links
- 102000006495 integrins Human genes 0.000 title abstract 4
- 108010044426 integrins Proteins 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001044646 | 2001-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350660T1 true ATE350660T1 (de) | 2007-01-15 |
Family
ID=18906601
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06013455T ATE412895T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression |
| AT02700679T ATE350660T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06013455T ATE412895T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7122318B2 (de) |
| EP (2) | EP1362601B8 (de) |
| JP (1) | JP4255285B2 (de) |
| KR (1) | KR20030080013A (de) |
| CN (2) | CN101025419A (de) |
| AT (2) | ATE412895T1 (de) |
| AU (1) | AU2002233677B2 (de) |
| CA (1) | CA2438427C (de) |
| DE (2) | DE60217300T2 (de) |
| ES (2) | ES2280502T3 (de) |
| WO (1) | WO2002066073A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030080013A (ko) | 2001-02-21 | 2003-10-10 | 에자이 가부시키가이샤 | 인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법 |
| CN1551766A (zh) * | 2001-09-05 | 2004-12-01 | ������������ʽ���� | 淋巴细胞活化抑制剂和自身免疫性疾病治疗剂 |
| WO2005090297A1 (en) * | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Sulphonamide derivatives |
| WO2006090927A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の摂食亢進作用 |
| MY153898A (en) | 2005-06-22 | 2015-04-15 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| FI20055498A0 (fi) * | 2005-09-16 | 2005-09-16 | Biotie Therapies Corp | Sulfonamidijohdannaisia |
| WO2007086605A1 (ja) * | 2006-01-27 | 2007-08-02 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の効果を予測する方法 |
| US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
| DK3873884T3 (da) | 2018-10-30 | 2025-02-17 | Gilead Sciences Inc | 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme |
| ES2987796T3 (es) | 2018-10-30 | 2024-11-18 | Gilead Sciences Inc | Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias |
| WO2020092401A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN |
| WO2020092394A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
| AU2020329207B2 (en) | 2019-08-14 | 2024-02-29 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
| RU2121997C1 (ru) * | 1993-09-10 | 1998-11-20 | Эйсай Ко., ЛТД | Производные 7-амино-1н-индола |
| JP2000507952A (ja) * | 1996-03-29 | 2000-06-27 | ジー．ディー．サール アンド カンパニー | ｍｅｔａ―置換フェニレンスルホンアミド誘導体 |
| SK163598A3 (en) * | 1996-05-31 | 1999-06-11 | Scripps Research Inst | Methods and compositions useful for inhibition of angiogenesis |
| WO1998044797A1 (en) * | 1997-04-07 | 1998-10-15 | Merck & Co., Inc. | A method of treating cancer |
| US6096707A (en) | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
| US6291503B1 (en) * | 1999-01-15 | 2001-09-18 | Bayer Aktiengesellschaft | β-phenylalanine derivatives as integrin antagonists |
| JP2000247949A (ja) | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| DE60141889D1 (de) | 2000-02-03 | 2010-06-02 | Eisai R&D Man Co Ltd | Inhibitoren der integrinexpression |
| KR20030080013A (ko) | 2001-02-21 | 2003-10-10 | 에자이 가부시키가이샤 | 인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법 |
-
2002
- 2002-02-21 KR KR10-2003-7010944A patent/KR20030080013A/ko not_active Ceased
- 2002-02-21 ES ES02700679T patent/ES2280502T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT06013455T patent/ATE412895T1/de active
- 2002-02-21 DE DE60217300T patent/DE60217300T2/de not_active Expired - Lifetime
- 2002-02-21 DE DE60229676T patent/DE60229676D1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02700679T patent/ATE350660T1/de active
- 2002-02-21 CN CNA2007100878177A patent/CN101025419A/zh active Pending
- 2002-02-21 CA CA2438427A patent/CA2438427C/en not_active Expired - Fee Related
- 2002-02-21 ES ES06013455T patent/ES2317368T3/es not_active Expired - Lifetime
- 2002-02-21 JP JP2002565631A patent/JP4255285B2/ja not_active Expired - Fee Related
- 2002-02-21 WO PCT/JP2002/001562 patent/WO2002066073A1/ja not_active Ceased
- 2002-02-21 CN CNB028086376A patent/CN100384482C/zh not_active Expired - Fee Related
- 2002-02-21 EP EP02700679A patent/EP1362601B8/de not_active Expired - Lifetime
- 2002-02-21 AU AU2002233677A patent/AU2002233677B2/en not_active Ceased
- 2002-02-21 EP EP06013455A patent/EP1742052B1/de not_active Expired - Lifetime
- 2002-02-21 US US10/468,615 patent/US7122318B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030080013A (ko) | 2003-10-10 |
| ES2280502T3 (es) | 2007-09-16 |
| DE60229676D1 (de) | 2008-12-11 |
| HK1099363A1 (en) | 2007-08-10 |
| EP1362601A1 (de) | 2003-11-19 |
| JP4255285B2 (ja) | 2009-04-15 |
| DE60217300T2 (de) | 2007-10-04 |
| JPWO2002066073A1 (ja) | 2004-06-17 |
| CA2438427C (en) | 2011-04-12 |
| AU2002233677B2 (en) | 2005-01-06 |
| HK1059038A1 (en) | 2004-06-18 |
| EP1742052B1 (de) | 2008-10-29 |
| WO2002066073A1 (en) | 2002-08-29 |
| EP1362601B8 (de) | 2007-02-28 |
| EP1362601B1 (de) | 2007-01-03 |
| ES2317368T3 (es) | 2009-04-16 |
| CN100384482C (zh) | 2008-04-30 |
| CN101025419A (zh) | 2007-08-29 |
| EP1742052A1 (de) | 2007-01-10 |
| DE60217300D1 (de) | 2007-02-15 |
| EP1362601A4 (de) | 2005-07-06 |
| US7122318B2 (en) | 2006-10-17 |
| CA2438427A1 (en) | 2002-08-29 |
| US20040132783A1 (en) | 2004-07-08 |
| ATE412895T1 (de) | 2008-11-15 |
| CN1620313A (zh) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60229676D1 (de) | Verfahren zur Untersuchung der Wirkung eines Angiogenese-Hemmers unter Vermittlung durch Hemmung der Integrin-Expression | |
| DE60124736D1 (de) | Vorrichtung zur messung des abschnittsweisen volumens und der elektrischen parallelleitfähigkeit einer herzkammer oder eines blutgefässes | |
| ATE404890T1 (de) | Verfahren und vorrichtung zur schnellen tomographischen messung der elektrischen leitfähigkeitsverteilung in einer probe | |
| WO2004113912A8 (en) | System and method for determining a temperature during analysis of biological fluid | |
| DE59608030D1 (de) | Verfahren und vorrichtung zur überprüfung eines sensors | |
| ATE265177T1 (de) | Vorrichtung, computersystem und computerprogramm zur bestimmung eines kardiovasculären parameters | |
| ATE551950T1 (de) | Verfahren zur messung von spannungszuständen eines materials und seine anwendung | |
| DE60315151D1 (de) | Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien | |
| Lawson et al. | Tear strength of five elastomeric impression materials at two setting times and two tearing rates | |
| ATE446561T1 (de) | Sensoranordnung | |
| ATE514951T1 (de) | Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse | |
| DE50205363D1 (de) | Feuchtigkeitsfühler mit kapazitivem Feuchte-Messelement und Verfahren zur Erfassung der Luftfeuchtigkeit | |
| DE60307448D1 (de) | Vorrichtung und verfahren zur messung der vaskulären impedanz | |
| EP4613181A4 (de) | Tragbare vorrichtung und verfahren zur verbesserung der genauigkeit von messungen eines physiologischen index | |
| DE602004024065D1 (de) | Verfahren und einrichtung zur hydrometeor-detektion | |
| DE602004024484D1 (de) | Vorrichtung und Verfahren zum Messen der Parameter bei Prüfungen während des Fluges eines Luftfahrzeug | |
| DE60112949D1 (de) | Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes | |
| ATE469347T1 (de) | Verfahren und vorrichtung zum testen eines objekts mit ultraschall | |
| ATE472427T1 (de) | Verfahren zur messung eines drucks | |
| DE60203524D1 (de) | Verfahren zur messung des arteriolendrucks | |
| BR0314638A (pt) | Equipamento de medição para medir dentaduras e diâmetros em componentes dinamicamente balançados | |
| DE50009357D1 (de) | Verfahren zur bestimmung der belastbarkeit eines menschen | |
| DE602008006604D1 (de) | Verfahren zur verarbeitung von spaltkammermesssignalen | |
| ATE397664T1 (de) | Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität | |
| ATE463671T1 (de) | Verfahren und vorrichtung zur messung der einspritzmenge und der einspritzrate eines einspritzventils für flüssigkeiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1362601 Country of ref document: EP |